Showing results (1861-1870 of 2,433) with videos related to
Sort By:
Pageof 244
Journal of the American Heart Association|August 9, 2021
What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD RegistrySuzanne V Arnold, Christopher P Cannon, James A de Lemos, et al.Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 5, 2008
Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypassDaniel J Stephens, John K Saunders, Scott Belsley, et al.Obesity Surgery|May 3, 2008
One-year readmission rates at a high volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and vertical banded gastroplasty-Roux-en-Y gastric bypassJohn Saunders, Garth H Ballantyne, Scott Belsley, et al.Journal of the American College of Cardiology|January 20, 2010
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) studyEric Y Yang, Vijay Nambi, Zhengzheng Tang, et al.The Bone & Joint Journal|November 1, 2022
Significant deterioration in quality of life and increased frailty in patients waiting more than six months for total hip or knee arthroplasty : a cross-sectional multicentre studyNick D Clement, Neil R Wickramasinghe, John M Bayram, et al.Scientific Reports|December 29, 2019
Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomesEric Y Yang, Mohammad A Khan, Edward A Graviss, et al.Cardiovascular Drugs and Therapy|September 4, 2020
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare SystemAkash Kataruka, Dhruv Mahtta, Julia M Akeroyd, et al.Diabetes Care|August 5, 2010
A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) studyL Maria Belalcazar, David M Reboussin, Steven M Haffner, et al.Diabetes Care|May 15, 2015
Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEADL Maria Belalcazar, Wei Lang, Steven M Haffner, et al.Journal of Clinical Lipidology|July 23, 2026
Projected impact of 2026 ACC/AHA/Multisociety Dyslipidemia Guideline on lipid-lowering therapy eligibility based on Class 1 and 2a recommendationsSameer A Sidiq, Geoffrey Y Zhang, Dmitry Abramov, et al.Pageof 244